• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Alexion

Anonymous board for Alexion
Replies
1
Views
174
anonymous
Replies
5
Views
2K
anonymous
Replies
10
Views
8K
Anonymous
Replies
6
Views
5K
anonymous
Replies
4
Views
4K
anonymous
Replies
54
Views
29K
anonymous
Replies
44
Views
32K
anonymous
Replies
75
Views
36K
anonymous
Replies
0
Views
2K
anonymous
Replies
3
Views
5K
anonymous
Replies
2
Views
3K
anonymous
Replies
5
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
66
Views
30K
anonymous
Replies
25
Views
16K
anonymous
Replies
2
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
0
Views
2K
anonymous
Replies
1
Views
2K
anonymous